This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Xiamen University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Qiaofeng Kang: Innovator in Pharmaceutical Compounds
Introduction
Qiaofeng Kang is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating tumors. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Qiaofeng Kang holds a patent for a substituted aryl ether compound, which includes a preparation method, pharmaceutical composition, and its use in medicine. The invention relates to a compound that can be utilized in the manufacture of a medicament for preventing or treating tumors. The patent details the specific formula and the various forms the compound can take, including stereoisomers, prodrugs, and pharmaceutically acceptable salts.
Career Highlights
Kang is affiliated with Xiamen University, where he continues to engage in research and development in the pharmaceutical sector. His work is characterized by a commitment to innovation and a focus on creating effective treatments for serious health conditions.
Collaborations
Throughout his career, Qiaofeng Kang has collaborated with esteemed colleagues, including Xianming Deng and Ting Zhang. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Qiaofeng Kang's contributions to pharmaceutical innovation are noteworthy, particularly his patented work on compounds for tumor treatment. His ongoing research at Xiamen University continues to impact the field positively.